BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37976317)

  • 1. Which institutional investors can improve the level of corporate ESG information disclosure?
    Wang J; Ke Y; Zhang H; Cheng Y
    PLoS One; 2023; 18(11):e0290008. PubMed ID: 37976317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of companies disclosing ESG reports in multiple languages on the enthusiasm of foreign investors for holding shares.
    Bao R; Wei L
    PLoS One; 2024; 19(3):e0299643. PubMed ID: 38452011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do Institutional Investors Influence Corporate Governance under Legal Psychology.
    Qi S
    J Environ Public Health; 2022; 2022():5004309. PubMed ID: 35978593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring or Colluding? Institutional Investors' Heterogeneity and Environmental Information Disclosure Behavior.
    Li Z; Zhang T; Zhao X; Zhu Y
    Front Psychol; 2022; 13():911901. PubMed ID: 35783741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From ratings to action: The impact of ESG performance on corporate innovation.
    Wang Y; Wang X
    Heliyon; 2024 Feb; 10(4):e26683. PubMed ID: 38420449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do disclosure of ESG information policies inhibit the value of heavily polluting Enterprises?-Evidence from China.
    Liu Y; Deng Y; Liu Y; Li C; Ankrah Twumasi M; Cheng Y
    Heliyon; 2023 Dec; 9(12):e22750. PubMed ID: 38125493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of ESG Information Into Individual Investors' Corporate Investment Decisions: Utilizing the UTAUT Framework.
    Park SR; Oh KS
    Front Psychol; 2022; 13():899480. PubMed ID: 35548525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the improvement of the social credit environment enhance corporate ESG scores?
    Han C; Chen B
    PLoS One; 2024; 19(3):e0300247. PubMed ID: 38530854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualified foreign institutional investors and corporate innovation: From the perspective of corporate governance.
    Wang X; Wang W; Shi XY
    Front Psychol; 2022; 13():1005409. PubMed ID: 36467163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can corporate ESG performance improve audit efficiency?: Empirical evidence based on audit latency perspective.
    Zhang L; Guo C
    PLoS One; 2024; 19(3):e0299184. PubMed ID: 38478565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can retail investors induce corporate green innovation? -Evidence from Baidu Search Index.
    Li M; Li N; Khan MA; Khaliq N; Rehman FU
    Heliyon; 2022 Jun; 8(6):e09663. PubMed ID: 35721685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESG performance, investor attention, and company reputation: Threshold model analysis based on panel data from listed companies in China.
    Meng T; Dato Haji Yahya MH; Ashhari ZM; Yu D
    Heliyon; 2023 Oct; 9(10):e20974. PubMed ID: 37876450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How does digital transformation affect the ESG performance of Chinese manufacturing state-owned enterprises?-Based on the mediating mechanism of dynamic capabilities and the moderating mechanism of the institutional environment.
    Jin X; Wu Y
    PLoS One; 2024; 19(5):e0301864. PubMed ID: 38743669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Institutional investors' site visits and investment-cash flow sensitivity: Mitigating financing constraints or inhibiting agent conflicts?
    Liao J; Zhan Y; Yuan Y
    PLoS One; 2024; 19(3):e0300332. PubMed ID: 38547151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How does ESG performance affect stock returns? Empirical evidence from listed companies in China.
    Yin XN; Li JP; Su CW
    Heliyon; 2023 May; 9(5):e16320. PubMed ID: 37305472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nexus of the CSR disclosures and corporate financial performance: evidence from Asian countries climate policy uncertainty.
    Waris M; Din BH
    Environ Sci Pollut Res Int; 2024 Jan; 31(2):1995-2008. PubMed ID: 38049691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental disclosure practices in mixed ownership models: A study of Chinese private enterprises.
    Song T; Xiong A
    PLoS One; 2023; 18(11):e0295399. PubMed ID: 38033167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating nutrition and obesity prevention considerations into institutional investment decisions regarding food companies: Australian investment sector perspectives.
    Robinson E; Parker C; Carey R; Foerster A; Blake MR; Sacks G
    Global Health; 2022 Nov; 18(1):93. PubMed ID: 36348484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying the effect of ESG-related news on Chinese stock movements.
    Chen Y; Zheng Y; Lv G; Gu Y; Zhang W
    J Environ Manage; 2024 Mar; 354():120301. PubMed ID: 38367504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Institutional investors and cost of capital: The moderating effect of ownership structure.
    Huo X; Lin H; Meng Y; Woods P
    PLoS One; 2021; 16(4):e0249963. PubMed ID: 33831116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.